Drug Trial Radar · NCT00017511
Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
Last checked: Nov 20, 2026Latest source record: May 16, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
Not stated
Start
Jun 2001
Primary completion
Mar 2003
Study completion Mar 2003
Sponsor
- Lead sponsor
- Daiichi SankyoDaiichi Sankyo (DSNKY)
- Sponsor type
- Industry
- First posted
- Jan 27, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Supportive care
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Cevimeline may be effective in treating dry mouth that is caused by radiation therapy for head and neck cancer. It is not yet known if cevimeline is more effective than no therapy in treating dry mouth caused by radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of cevimeline in treating patients who have dryness of the mouth caused by radiation therapy for head and neck cancer.
Conditions
- Head and Neck Cancer
- Oral Complications
- Radiation Toxicity
Interventions
cevimeline hydrochlorideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
71 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama
Mobile Infirmary Medical Center
Mobile, Alabama
Cranial Pain Research
Tucson, Arizona
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Alta Bates Comprehensive Cancer Center
Berkeley, California
Jonsson Comprehensive Cancer Center, UCLA
Los Angeles, California
Chao Family Comprehensive Cancer Center
Orange, California
Radiation Oncology Center - Sacramento
Sacramento, California
Rebecca and John Moores UCSD Cancer Center
San Diego, California
Stanford University Medical Center
Stanford, California
Colorado Otolaryngology Associates
Colorado Springs, Colorado
University of Connecticut Health Center
Farmington, Connecticut
Walter Reed Army Medical Center
Washington D.C., District of Columbia
Innovative Medical Research of South Florida, Inc.
Miami, Florida
Medical College of Georgia Hospital and Clinics
Augusta, Georgia
Kootenai Medical Center
Coeur d'Alene, Idaho
University of Illinois at Chicago
Chicago, Illinois
University of Chicago Cancer Research Center
Chicago, Illinois
Evanston Northwestern Health Care
Evanston, Illinois
University of Kansas Medical Center
Kansas City, Kansas
Central Baptist Hospital
Lexington, Kentucky
James Graham Brown Cancer Center
Louisville, Kentucky
Site not named
Louisville, Kentucky
Tulane Cancer Center
New Orleans, Louisiana
Harbor Hospital Center
Baltimore, Maryland
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland
Dana-Farber Cancer Institute
Boston, Massachusetts
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan
Ear, Nose, and Throat Specialty Care of Minnesota, P.A.
Minneapolis, Minnesota
University of Minnesota School of Dentistry
Minneapolis, Minnesota
University of Mississippi Medical Center
Jackson, Mississippi
University of Missouri
Columbia, Missouri
Siteman Cancer Center
St Louis, Missouri
University of Nebraska Medical Center
Lincoln, Nebraska
University of Nebraska Medical Center
Omaha, Nebraska
Norris Cotton Cancer Center
Lebanon, New Hampshire
Hackensack University Medical Center
Hackensack, New Jersey
Monmouth Medical Center
Long Branch, New Jersey
Professional Otolaryngology Associates
Voorhees Township, New Jersey
North Shore University Hospital
Manhasset, New York
Showing 40 of 71 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.